The State of Commercial Reimbursement: Q3 2026

Press-pitch lede: Ask a hospital finance director which state has the "most expensive" care, and you'll get a confident, wrong answer. Medlyze's review of hospitals' own published price files found the real answer changes with the procedure — New York's surgical rates run up to 12x the cheapest state on file, but for emergency care, Texas outranks New York entirely. There is no single most-expensive state in American healthcare. There's a most-expensive state per procedure — and betting a network or benchmark strategy on the wrong one is how employers overpay for care they never saw coming.

Methodology

Negotiated commercial rates for four common procedures, across the 8 states with the most rate data on file, filtered to remove clear parsing artifacts (any rate under $50 excluded — a $0.01 "negotiated rate" for a rotator cuff repair is a data error, not a price). Median taken per state to avoid a handful of outlier contracts skewing the picture. Source: hospitals' own published price transparency machine-readable files.

Headline finding

Ask a reporter "which state has the most expensive hospital care" and they'll name New York or California with total confidence. That answer is wrong for roughly half of what a health plan actually pays for.

The same procedure can cost 5 to 12 times more in one state than another — and which state sits at the top of that range flips depending on the procedure.

New York is the most expensive state for every scheduled surgical procedure we tested. For emergency care, it isn't — Texas takes that spot instead, well ahead of New York specifically (4.5x). That reversal is the finding, not the multiples themselves. Commercial reimbursement risk isn't a place; it's a place-times-procedure combination. Any index, scorecard, or "cost of care" ranking that collapses to one number per state is quietly averaging over that reversal — and every average has a category it's flattering and one it's hiding.

What this means, by audience

RCM / managed care teams: We keep seeing the same shortcut — one regional cost index used to greenlight renewal priorities across three unrelated service lines in the same quarter. It's fast, and it's also how a system leaves surgical lines underpriced (they're actually above regional average) while over-investing in renegotiating ED/observation contracts that were never as expensive as the index implied. That's a pattern we see repeatedly across RCM teams, not one client's story — but it's common enough to name. Pull the state-and-procedure-specific number before the renewal, not after.

Employers / brokers: "Reasonable market rate" isn't one number nationally, or even one number per state. Plan sponsors who get burned usually aren't ignoring geography — they ran the analysis once, for one procedure, and assumed it travels. It doesn't. Emergency care and scheduled surgery move independently, sometimes in opposite directions, inside the same state.

Self-insured plan sponsors evaluating reference-based pricing: this is the procedure-by-procedure, state-by-state variance our reference-based pricing benchmark guide covers for one procedure (knee replacement) — extended across categories here. The costly version of this mistake: calibrating an RBP percentage-of-Medicare benchmark to one procedure in one region, then applying it plan-wide. A benchmark tuned to lumbar spine surgery in New York tells you almost nothing about what's reasonable for an ED visit in Iowa.

Next edition

Q4 2026: same 4 procedures, tracking whether the spread narrows or widens, plus 2 new procedure categories. Building a trend, not a snapshot, is the actual differentiator against static one-time scorecards — see Medlyze's network coverage analysis if you want this cut for a specific payer footprint rather than a national one.